Label composition: BPC-157 · GHK-Cu / Copper Peptide · TB-500 · KPV
BPC-157 + GHK-Cu + TB-500 + KPV Stack
$179.00
KLOW brings four label-identified components into one broad formulation: BPC-157, GHK-Cu, TB-500, and KPV. Its distinction is the breadth of the stack, spanning compounds represented across peptide-signaling, skin-biology, and tissue-related research.
10 in stock
KLOW brings four label-identified components into one broad formulation: BPC-157, GHK-Cu, TB-500, and KPV. Its distinction is the breadth of the stack, spanning compounds represented across peptide-signaling, skin-biology, and tissue-related research.
Understand the formulation
The references below explain selected component research. They do not demonstrate that combining the four components produces an additive, synergistic, or clinical effect.
Systematic review · predominantly preclinical
A systematic review found predominantly preclinical evidence and no clinical safety data for BPC-157.
PubMed (PMID 40756949)
Review authoritative source : PubMed (PMID 40756949)Peer-reviewed review · biological and translational context
A peer-reviewed review describes GHK-Cu chemistry and research involving collagen, fibroblasts, and tissue-remodeling pathways.
PubMed (PMID 18644225)
Review authoritative source : PubMed (PMID 18644225)Animal research · preclinical
A study evaluated KPV in two mouse models of intestinal inflammation. It is preclinical evidence and does not establish a human outcome.
PubMed (PMID 18092346)
Review authoritative source : PubMed (PMID 18092346)Research references describe the cited compounds or biological context; they do not establish a guaranteed outcome for this product or formulation.
